Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Pediatric Nephrology (Berlin, Germany)|August 1, 2022
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trialWesley Hayes, David J Sas, Daniella Magen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young childrenDavid J Sas, Daniella Magen, Wesley Hayes, et al.
Kidney International Reports|July 31, 2024
Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: Results from a Phase III Clinical TrialJeffrey M Saland, John C Lieske, Jaap W Groothoff, et al.
Kidney Medicine|November 10, 2025
Natural History of Advanced Primary Hyperoxaluria Type 1: A Retrospective StudyJohn C Lieske, Jaap W Groothoff, Yaacov Frishberg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 17, 2022
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C TrialMini Michael, Jaap W Groothoff, Hadas Shasha-Lavsky, et al.
Kidney International Reports|March 8, 2022
Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1Sally A Hulton, Jaap W Groothoff, Yaacov Frishberg, et al.
Kidney International Reports|October 18, 2023
Diagnostic Utility of Exome Sequencing Among Israeli Children With Kidney FailureYishay Ben-Moshe, Omer Shlomovitz, Danit Atias-Varon, et al.
The New England Journal of Medicine|March 31, 2021
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1Sander F Garrelfs, Yaacov Frishberg, Sally A Hulton, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 17, 2023
Genetic Markers Among the Israeli Druze Minority Population With End-Stage Kidney DiseaseOmer Shlomovitz, Danit Atias-Varon, Dina Yagel, et al.
Pageof 2